A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2018
At a glance
- Drugs Lemborexant (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 16 Oct 2018 Status changed from active, no longer recruiting to completed.
- 13 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Mar 2018 New trial record